Recursion (NASDAQ: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Chris Gibson, Ph.D., will complete his current term through June ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cellino Biotech, Inc., a biotechnology company advancing autonomous, closed biomanufacturing for personalized regenerative medicines, today announced the appointment ...

SAUGERTIES, N.Y. — Former U.S. Rep. Chris Gibson will be the featured speaker at the Ulster County Regional Chamber of Commerce Breakfast Meeting on Wednesday, Nov. 19, according to an announcement.

Amid a flurry of federal funding cuts at the National Institute of Health (NIH) over the past few weeks as a result of President Donald Trump’s executive actions, one CEO is stepping up to support ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

In 1981, the day after his 17th birthday, Chris Gibson enlisted in the Army National Guard. Still in high school, he started off as a private in the infantry. Later, when he was attending Siena ...

Join special guest speaker Chris Gibson, former U.S. Congressman for New York’s 19th and 20th District and a retired Army colonel with over 24 years of service, for a discussion followed by a Q&A ...

“We are thrilled to welcome Chris to our board. As a seasoned founder and CEO, his hands-on experience and operational insights will be invaluable as we scale our team and vision for patient impact,” ...